Clinical Trial

Chinese Second Hip Fracture Evaluation

Study acronym: CSHFE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 17, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
1. To Compare overall rates of second hip fractures in both genders, 2. To determine the effect of hip fracture on proximal femoral volumetric bone mineral density (vBMD), bone structure and muscle by quantitative computed tomography(QCT), 3. To evaluate the contribution of QCT-image analysis to the prediction of the second hip fracture risk. 4. To identify the differences between femoral neck fracture and trochanter fracture following hip fracture
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2018-03-05; most recent amendment 2025-08-13.
Trial Details
NCT Number NCT03461237
Lead Sponsor Beijing Jishuitan Hospital
Conditions Hip Fractures, Osteoporosis
Enrollment 3,000 participants
Start Date 2017-05-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-08-17